K Number
K040109
Device Name
HEMORRHAGE OCCLUDER PIN
Date Cleared
2004-03-25

(65 days)

Product Code
Regulation Number
878.4750
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Hemorrhage Occluder Pin is indicated for the control of localized severe presacral hemorrhage during pelvic surgery. When other techniques (cautery, suture, clamping, etc.) are judged ineffective.
Device Description
The Hemorrhage Occluder Pin is a 7 mm long pin capped with an 8 mm diameter, 1.5 mm thick truncated conc-shaped head. The 1.25 mm diameter pin section has four tissue and bone retaining ridges formed by machining four equally spaced truncated conical sections. It is made of medical grade titanium suitable for implantation.
More Information

Not Found

No
The description focuses on the physical characteristics and intended use of a mechanical device, with no mention of AI, ML, image processing, or data analysis.

Yes
The device is described as controlling hemorrhage during surgery, which directly addresses a health condition (hemorrhage) by alleviating it.

No
The device is described as a Hemorrhage Occluder Pin used for controlling localized severe presacral hemorrhage during pelvic surgery. Its function is to physically stop bleeding, not to diagnose a condition.

No

The device description explicitly states it is a physical pin made of medical grade titanium, which is a hardware component.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used outside of the body (in vitro).
  • Device Description and Intended Use: The Hemorrhage Occluder Pin is a physical device designed to be implanted within the body during surgery to control bleeding. It directly interacts with tissue and bone.

The description clearly indicates a surgical implant used in vivo (within the living body), not a test performed on a sample in vitro.

N/A

Intended Use / Indications for Use

This device is indicated to control severe presacral hemorrhage during pelvic surgery.

For the control of localized severe hemorrhage from the presacral area during surgery.

When other techniques (cautery, suture, clamping, etc.) are judged ineffective.

The Hemorrhage Occluder Pin is indicated for the control of localized severe presacral hemorrhage during pelvic surgery. The pin is used to occlude internal tissue to stop hemorrhage. The Hemorrhage Occluder Pin is indicated for the control of hemorrhage and to aid healing.

Product codes (comma separated list FDA assigned to the subject device)

GDW

Device Description

The Hemorrhage Occluder Pin is a 7 mm long pin capped with an 8 mm diameter, 1.5 mm thick truncated conc-shaped head. The 1.25 mm diameter pin section has four tissue and bone retaining ridges formed by machining four equally spaced truncated conical sections. It is made of medical grade titanium suitable for implantation.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

sacral area during pelvic surgery.

Indicated Patient Age Range

All males or females with the above indication for use.

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K890447

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 878.4750 Implantable staple.

(a)
Identification. An implantable staple is a staple-like device intended to connect internal tissues to aid healing. It is not absorbable.(b)
Classification. Class II.

0

040109 (p. 1 of 3)

510(k) SUMMARY (Section E)

1.Submitted by:Tools for Surgery, LLC
2.Address:1339 Stony Brook Road
Stony Brook, NY 11790
3.Telephone:(631) 751-6930
4.Fax:(631) 751-6932
5.Contact Person:Arnold R. Leiboff, M.D.
6.Date Summary Prepared:January 6, 2004
7.Device Trade Name:Hemorrhage Occluder Pin
8.Common Name:Hemorrhage Occluder Pin, also thumbtack
9.Classification Name:Staple, Implantable (per 21 CFR, Section 878 4750)

Substantial Equivalency is claimed against the following device: Hemorrhage Occluder Pin 10. from Surgin, Inc. 510(k) K890447

Description of the Device: The Hemorrhage Occluder Pin is a 7 mm long pin capped with 11. an 8 mm diameter, 1.5 mm thick truncated conc-shaped head. The 1.25 mm diameter pin section has four tissue and bone retaining ridges formed by machining four equally spaced truncated conical sections. It is made of medical grade titanium suitable for implantation.

Intended use of the device: This device is indicated to control severe presacral hemorrhage l 2. during pelvic surgery.

Safety and effectiveness of this device: This device is as safe and effective as the predicate 13. device cited above. See tabulated comparison (paragraph 14 below) to validate this claim,

Summary comparing technological characteristics with the predicate device. Please find 14. below a tabulated comparison supporting that this device is substantially equivalent to the predicate medical device in commercial distribution.

1

SUBSTANTIAL EQUIVALENCE COMPARISON

Proposed DevicePredicate Device
Intended UseFor the control of localized severe
hemorrhage from the presacral area
during surgery.Exactly the same
Indications for UseWhen other techniques (cautery, suture,
clamping, etc.) are judged ineffective.Exactly the same
Target PopulationAll males or females with the above
indication for use.Exactly the same
DesignSee item 11 of 510(k) summary (page
4.1) and drawing (page 4.4) The
proposed device was developed by
reverse engineering the predicate device.Exactly the same
MaterialsMachined from medical grade 6AL4V
titanium as are many orthopedic devices
such as hip and knee joints and pins,
plates and screws, etc. used for internal
and external bone fracture fixationExactly the same
PerformanceSterile single use device is pressed thru
the tissue and imbedded in the bone at
the presacral hemorrhage site (using
fingertip pressure) until the head is
seated and the bleeding controlled. The
pin, abetted by the ridges on the pin,
remains implanted in the bone. Clinical
experience of the product device
validates the performance.Exactly the same
BiocompatibilityTitanium is known to be completely inert
and immune to corrosion by all body
fluids and tissue and is capable of joining
with bone and other tissue. Also, the
prior clinical experience with the
predicate pins of the same material,
sterilized and implanted in the sacral area
during pelvic surgery validates the
biocompatibility .Exactly the same, i.e
same manufacturing
process, same
chemical composition,
same body contact and
equivalent sterilization
method.
Mechanical SafetySupported by materials high strength,
corrosion resistance, ability to withstand
repeated sterilizations without
compromise to edge or surface quality
and by its identical design to the
predicate device with its long successful
clinical usageExactly the same
Chemical SafetySupported by safe usage of much larger
volume of identical material in imbedded
prostheses and the materials bio-
compatibility.Exactly the same
Anatomical SitesOnly site indicated for usage is in the
sacral area during pelvic surgery.Exactly the same
Human FactorsNot an issue. Only finger pressure
required to pierce tissue and to press pin
into the bone.Exactly the same
Energy Used or
DeliveredNone.None
Compatibility with
environmental and
other devicesMaterial is highly inert, chemically safe
and non-magnetic and is thus no threat to
environment or sensitive implanted
devices, electronic or otherwise.Exactly the same
Standards MetMIL-T9047 6AL4V EL1 ASTM F136.Exactly the same
Electrical SafetyDevice is passive. No electrical input,
output or generated power.Exactly the same
Thermal SafetyDevice is passive, not heat generating,
and immune to damage from external
heat within range the body can otherwise
sustain without fatal consequences.Exactly the same
Radiation SafetyDevice is immune to damage by any
level of radiation exposure the body can
sustain and does not emit any radiation.Exactly the same
SterilityThe device is to be marketed both as
"unsterilized" and as "sterilized". The
latter will be ETO sterilized and
validated in accordance with
ANSI/AAMI 11135-1994 and EN550.
Sterilization validated per method "c",
half cycle method.
For the sterilized device the packaging
shall be a double barrier consisting of a
tyvek-styrene tray in a tyvek-
polyethylene pouch with a five year
  • expiration. A packaging aging study will
    be completed by a certified testing. | Radiation sterilization
    when marketed as
    sterilized. Packaging
    and expiration is
    exactly the same. |

2

K$\Phi$t$\rho$1$\varphi$9 (P.3.$\rho$3)

:

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines that suggest feathers or wings.

MAR 2 5 2004

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Arnold R. Leiboff, M.D. President Tools For Surgery, LLC 1339 Stony Brook Road Stony Brook, New York 11790

Re: K040109

Trade/Device Name: Hemorrhage Occluder Pin Regulation Number: 21 CFR 878.4750 Regulation Name: Implantable staple Regulatory Class: II Product Code: GDW Dated: January 6, 2004 Received: January 20, 2004

Dear Dr. Leiboff:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the cnclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

4

Page 2 - Arnold R. Leiboff, M.D.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Mark A. Mulkerson

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

Indications for Use

510(k) Number (if known):_K040109

Device Name:__________________________________________________________________________________________________________________________________________________________________

Indications For Use:

The Hemorrhage Occluder Pin is indicated for the control of iocalized severe presacral
e international contributers and in a occlude internal tissue to stop hemorrhage The Hemorrhage Occluder Pin is Indicated for the control of Good of Collection of Stop hemorrhage and aid healing.

Prescription Use ਮ (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Mark A. Milliken

Division of General, Restorative, and Neurological Devices

Page 1 of 1

Number K090104